WallStreetZenWallStreetZen

NASDAQ: CRDL
Cardiol Therapeutics Inc Stock

$1.85-0.04 (-2.12%)
Updated Jun 21, 2024
CRDL Price
$1.85
Fair Value Price
$0.39
Market Cap
$118.58M
52 Week Low
$0.66
52 Week High
$3.12
P/E
-5.39x
P/B
8.1x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$22.22M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.55
Operating Cash Flow
-$16M
Beta
1.39
Next Earnings
Aug 8, 2024
Ex-Dividend
N/A
Next Dividend
N/A

CRDL Overview

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses developing anti-fibrotic and anti-inflammatory therapies to treat cardiovascular disease. Its lead product is CardiolRx, which reduces cardiovascular and respiratory events in patients hospitalized with COVID-19. The company is also developing a subcutaneous formulation of CardiolRx to treat fibrosis and inflammation that progress to heart failure. Cardiol Therapeutics was incorporated in 2017 and is headquartered in Oakville, Ontario, Canada.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CRDL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CRDL ($1.85) is overvalued by 370.46% relative to our estimate of its Fair Value price of $0.39 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CRDL ($1.85) is not significantly undervalued (370.46%) relative to our estimate of its Fair Value price of $0.39 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CRDL is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CRDL due diligence checks available for Premium users.

Be the first to know about important CRDL news, forecast changes, insider trades & much more!

CRDL News

Valuation

CRDL fair value

Fair Value of CRDL stock based on Discounted Cash Flow (DCF)
Price
$1.85
Fair Value
$0.39
Overvalued by
370.46%
CRDL ($1.85) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CRDL ($1.85) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CRDL is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CRDL price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-5.39x
Industry
1.17x
Market
30.75x

CRDL price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
8.1x
Industry
2.15x
CRDL is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CRDL's financial health

Profit margin

Revenue
$0.0
Net Income
-$6.7M
Profit Margin
0%
CRDL's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$22.9M
Liabilities
$8.1M
Debt to equity
0.55
CRDL's short-term assets ($22.36M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CRDL's short-term assets ($22.36M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CRDL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$5.1M
Investing
-$2.5k
Financing
$56.1k
CRDL's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CRDL vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
CRDL$118.58M-2.12%-5.39x8.10x
OPTN$123.21M-3.54%-4.04x-1.24x
ASRT$109.39M-0.86%-0.32x0.81x
DERM$103.67M-5.30%-25.90x8.00x
INCR$97.07M-0.93%-5.87x0.80x

Cardiol Therapeutics Stock FAQ

What is Cardiol Therapeutics's quote symbol?

(NASDAQ: CRDL) Cardiol Therapeutics trades on the NASDAQ under the ticker symbol CRDL. Cardiol Therapeutics stock quotes can also be displayed as NASDAQ: CRDL.

If you're new to stock investing, here's how to buy Cardiol Therapeutics stock.

What is the 52 week high and low for Cardiol Therapeutics (NASDAQ: CRDL)?

(NASDAQ: CRDL) Cardiol Therapeutics's 52-week high was $3.12, and its 52-week low was $0.66. It is currently -40.71% from its 52-week high and 179.88% from its 52-week low.

How much is Cardiol Therapeutics stock worth today?

(NASDAQ: CRDL) Cardiol Therapeutics currently has 64,097,536 outstanding shares. With Cardiol Therapeutics stock trading at $1.85 per share, the total value of Cardiol Therapeutics stock (market capitalization) is $118.58M.

Cardiol Therapeutics stock was originally listed at a price of $2.39 in Aug 10, 2021. If you had invested in Cardiol Therapeutics stock at $2.39, your return over the last 2 years would have been -22.59%, for an annualized return of -12.02% (not including any dividends or dividend reinvestments).

How much is Cardiol Therapeutics's stock price per share?

(NASDAQ: CRDL) Cardiol Therapeutics stock price per share is $1.85 today (as of Jun 21, 2024).

What is Cardiol Therapeutics's Market Cap?

(NASDAQ: CRDL) Cardiol Therapeutics's market cap is $118.58M, as of Jun 24, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Cardiol Therapeutics's market cap is calculated by multiplying CRDL's current stock price of $1.85 by CRDL's total outstanding shares of 64,097,536.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.